RBV Capital is a venture capital and private equity firmInvesting in life science technology companies that is headquartered in Moscow, Russia and was founded in 2014 by Alexey Konov and Robert Karl. The firm also has a partnership office in Wilen, Switzerland. Sectors RBV invest in include: life science, pharmaceuticals, biologics, digital healthcare products, and medical devices. Notable investments made by RBV Capital include: RetroSense Therapeutics, Bonti, Image Analysis Ltd., Immusoft, Botkin.AI, and AGCT.
Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.